We have also developed a method for the directional insertion of polyA signals (PASs) upstream of the DMPK CTG repeats in DM1-03 iPSCs, which eliminates nuclear RNA foci and reverses the phenotype of MBNL1. The gene discussed is DMPK; the disease is myotonic dystrophy type 1.